InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Relay Therapeutics, Inc.

RLAY Clue Score52
United States Fiscal year ends December CIK 0001812364 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

50
Insider
Date
Role
Action
Shares
Price
Amount
Donald A Bergstrom
22 Jun 2026
President, R&D
Sold after exercise
93,456
$16.94
$1.58M
Thomas Catinazzo
22 Jun 2026
Chief Financial Officer
Sold after exercise
51,560
$16.97
$874.97K
Thomas Catinazzo
22 Jun 2026
Chief Financial Officer
Sold after exercise
61,563
$16.97
$1.04M
Thomas Catinazzo
22 Jun 2026
Chief Financial Officer
Sold after exercise
56,323
$16.97
$955.80K
Thomas Catinazzo
22 Jun 2026
Chief Financial Officer
Sold after exercise
17,717
$17.01
$301.37K
Thomas Catinazzo
9 Apr 2026
Chief Financial Officer
Sold after exercise
1,800
$15.00
$27.00K
Sanjiv Patel
26 Jul 2024
President and CEO
Sold after exercise
36,706
$9.07
$332.92K
Sanjiv Patel
25 Jul 2024
President and CEO
Sold after exercise
50,000
$9.16
$458.00K
Sanjiv Patel
9 Feb 2023
President and CEO
Sold after exercise
14,000
$20.55
$287.70K
Sanjiv Patel
8 Feb 2023
President and CEO
Sold after exercise
14,000
$20.98
$293.72K
Sanjiv Patel
7 Feb 2023
President and CEO
Sold after exercise
14,000
$21.45
$300.30K
Sanjiv Patel
19 Jan 2023
President and CEO
Sold after exercise
28,000
$20.02
$560.56K
Sanjiv Patel
18 Jan 2023
President and CEO
Sold after exercise
28,000
$20.87
$584.36K
Sanjiv Patel
17 Jan 2023
President and CEO
Sold after exercise
28,000
$20.23
$566.44K
Sanjiv Patel
10 Nov 2022
President and CEO
Sold after exercise
9,825
$20.00
$196.50K
Sanjiv Patel
10 Nov 2022
President and CEO
Sold after exercise
18,175
$20.00
$363.50K
Sanjiv Patel
8 Nov 2022
President and CEO
Sold after exercise
14,000
$20.18
$282.52K
Donald A Bergstrom
1 Nov 2022
President, R&D
Sold after exercise
8,000
$22.75
$182.00K
Sanjiv Patel
13 Oct 2022
President and CEO
Sold after exercise
14,000
$20.58
$288.12K
Sanjiv Patel
12 Oct 2022
President and CEO
Sold after exercise
14,000
$21.18
$296.52K
Sanjiv Patel
11 Oct 2022
President and CEO
Sold after exercise
14,000
$21.36
$299.04K
Donald A Bergstrom
3 Oct 2022
President, R&D
Sold after exercise
8,000
$22.43
$179.44K
Sanjiv Patel
15 Sep 2022
President and CEO
Sold after exercise
14,000
$23.80
$333.20K
Sanjiv Patel
14 Sep 2022
President and CEO
Sold after exercise
14,000
$23.47
$328.58K
Sanjiv Patel
13 Sep 2022
President and CEO
Sold after exercise
14,000
$25.45
$356.30K
Donald A Bergstrom
8 Sep 2022
President, R&D
Sold after exercise
25,000
$30.00
$750.00K
Thomas Catinazzo
8 Sep 2022
Chief Financial Officer
Sold after exercise
26,257
$30.00
$787.71K
Donald A Bergstrom
2 Sep 2022
President, R&D
Sold after exercise
4,900
$25.46
$124.75K
Donald A Bergstrom
1 Sep 2022
President, R&D
Sold after exercise
8,100
$23.07
$186.87K
Donald A Bergstrom
24 Aug 2022
President, R&D
Sold after exercise
15,000
$25.00
$375.00K
Donald A Bergstrom
5 Aug 2022
President, R&D
Sold after exercise
8,000
$20.00
$160.00K
Donald A Bergstrom
6 Jul 2022
President, R&D
Sold after exercise
8,000
$20.00
$160.00K
Donald A Bergstrom
24 Jun 2022
President, R&D
Sold after exercise
8,000
$20.00
$160.00K
Donald A Bergstrom
2 May 2022
President, R&D
Sold after exercise
13,000
$24.62
$320.06K
Sanjiv Patel
14 Apr 2022
President and CEO
Sold after exercise
14,000
$30.51
$427.14K
Sanjiv Patel
14 Apr 2022
President and CEO
Sold after exercise
14,000
$30.51
$427.14K
Sanjiv Patel
13 Apr 2022
President and CEO
Sold after exercise
14,000
$31.94
$447.16K
Sanjiv Patel
13 Apr 2022
President and CEO
Sold after exercise
14,000
$31.96
$447.44K
Sanjiv Patel
12 Apr 2022
President and CEO
Sold after exercise
28,000
$31.80
$890.40K
Donald A Bergstrom
1 Apr 2022
President, R&D
Sold after exercise
18,000
$30.32
$545.76K
Donald A Bergstrom
24 Mar 2022
President, R&D
Sold after exercise
10,000
$30.00
$300.00K
Thomas Catinazzo
24 Mar 2022
Chief Financial Officer
Sold after exercise
13,286
$30.00
$398.58K
Donald A Bergstrom
10 Mar 2022
President, R&D
Sold after exercise
10,000
$25.00
$250.00K
Donald A Bergstrom
1 Mar 2022
President, R&D
Sold after exercise
8,000
$23.88
$191.04K
Donald A Bergstrom
22 Feb 2022
President, R&D
Sold after exercise
2,752
$20.97
$57.71K
Donald A Bergstrom
22 Feb 2022
President, R&D
Sold after exercise
12,242
$20.94
$256.35K
Donald A Bergstrom
22 Feb 2022
President, R&D
Sold after exercise
8,000
$20.94
$167.52K
Brian Adams
15 Nov 2021
General Counsel
Sold after exercise
6,500
$35.42
$230.23K
Thomas Catinazzo
15 Nov 2021
Senior Vice President, Finance
Sold after exercise
22,500
$35.40
$796.50K
Thomas Catinazzo
13 Sep 2021
Senior Vice President, Finance
Sold after exercise
22,500
$35.00
$787.50K
Showing 250 of 278 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 292
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 51
Sales straight out of an exercise 57
Sales at will 164
Transactions with no price 0
Shares from compensation/vesting 50,611,237
Sales filed before the plan box existed 57
History held since 20 Jul 2020